Dongsung Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dongsung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Celltrion Pharm Incorporated
sales of 74.73 billion Korean Won [US$65.76 million]
of which 100%
Nutri Biotech Co Ltd
(77.52 billion Korean Won [US$68.21 million]
JW Shinyak Corp
(76.95 billion Korean Won [US$67.71 million]
Dongsung Pharmaceutical Company Limited reported sales of 74.66 billion Korean Won (US$65.70 million)
December of 2015.
increase of 2.1%
versus 2014, when the company's sales were 73.16 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Dongsung Pharmaceutical Company Limited
reported sales of 75.18 billion Korean Won.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Dongsung Pharmaceutical Company Limited had sales
of 71.93 billion Korean Won.
Sales of Cosmetics/toilet Preparation Segment saw an increase
that was more than double the company's growth rate: sales were up
16.5% in 2015, from
9.09 billion Korean Won to 10.59 billion Korean Won.